Centene (NYSE:CNC) Earns "Outperform" Rating from Oppenheime

Centene (NYSE:CNC – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Oppenheimer in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $110.00 target price on the stock. Oppenheimer’s price objective indicates a potential upside of 48.59% from the company’s current price. Other […]

Related Keywords

United States , Kennethj Fasola , Lori Jean Robinson , Centene Corporation , Wells Fargo Company , Securities Exchange Commission , Rise Advisors , Turtle Creek Wealth Advisors , Barclays , Cantor Fitzgerald , Riggs Asset Managment Co , Operose Advisors , Get Free Report , Director Lori Jean Robinson , President Kenneth , Exchange Commission , Creek Wealth Advisors , Asset Management , Riggs Asset Managment , Centene Daily , Centene , Nyse Cnc , Cnc , Medical , 15135b10 , Reiterated Rating , Oppenheimer Holdings Inc ,